Loading…
Loading…

| LLYLLYEli Lilly and Company | Eli Lilly and Company | $1,279.14 | $1.2T |
| MRKMRKMerck & Co., Inc. | Merck & Co., Inc. | $140.61 | $346.9B |
| NVSNVSNovartis AG | Novartis AG | $153.81 | $292.3B |
| AZNAZNAstraZeneca PLC | AstraZeneca PLC | $172.06 | $266.8B |
| AMGNAMGNAmgen Inc. | Amgen Inc. | $444.63 | $240.4B |
| GILDGILDGilead Sciences, Inc. | Gilead Sciences, Inc. | $158.69 | $196.8B |
| NVONVONovo Nordisk A/S | Novo Nordisk A/S | $39.13 | $173.0B |
| PFEPFEPfizer Inc. | Pfizer Inc. | $29.79 | $169.8B |
| BMYBMYBristol-Myers Squibb Company | Bristol-Myers Squibb Company | $61.61 | $125.9B |
| GSKGSKGSK plc | GSK plc | $51.10 | $102.4B |